FATE icon

Fate Therapeutics

169 hedge funds and large institutions have $203M invested in Fate Therapeutics in 2023 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 59 increasing their positions, 54 reducing their positions, and 36 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less funds holding

Funds holding:

less ownership

Funds ownership:

less first-time investments, than exits

New positions opened: | Existing positions closed:

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

61% less capital invested

Capital invested by funds: $520M → $203M (-$317M)

87% less call options, than puts

Call options by funds: $4K | Put options by funds: $31K

Holders
169
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$4K
Puts
$31K
Net Calls
Net Calls Change

Top Buyers

1 +$3.05M
2 +$2.62M
3 +$1.79M
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$1.08M
5
BlackRock
BlackRock
New York
+$1.07M

Top Sellers

1 -$17M
2 -$7.96M
3 -$4.55M
4
Voloridge Investment Management
Voloridge Investment Management
Florida
-$3.97M
5
Citigroup
Citigroup
New York
-$2.26M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$27.8M
2
$26.5M
3
$23.1M
4
$10.3M
5
$9.99M
6
$7.16M
7
$5.5M
8
$5.2M
9
$5.06M
10
$4.82M
11
$4.55M
12
$4.38M
13
$4.35M
14
$4.28M
15
$4.1M
16
$3.92M
17
$3.76M
18
$3.5M
19
$3.03M
20
$2.65M
21
$2.07M
22
$1.88M
23
$1.54M
24
$1.52M
25
$1.48M